National Center for Complementary and Integrative Health (NCCIH)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Center for Complementary and Integrative Health (NCCIH) sits in the top decile of US sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count).
National Center for Complementary and Integrative Health (NCCIH): 203 sponsored US clinical trials, 6 recruiting.
National Center for Complementary and Integrative Health (NCCIH) sponsors 203 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 189 completed. 15 of these trials are in Phase 3-4 (later-stage) and 142 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 6 trials.
Top-decile sponsor footprint
National Center for Complementary and Integrative Health (NCCIH) ranks in the top decile of sponsors by registered trial count (#152 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
189 of 195 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
203 total, page 3 of 5
Comparing Effects of 3 Sources of Garlic on Cholesterol Levels
NCT00056511
Treatment of Depression With Massage in HIV
NCT00033852
Mindfulness-Based Art Therapy for Cancer Patients
NCT00034970
Physical CAM Therapies for Chronic Low Back Pain
NCT00065975
Self-Hypnotic Relaxation Therapy During Invasive Procedures
NCT00087841
Ethnopharmacological Studies in Oral Medicine
NCT00200837
Effects of Ginseng and Ginkgo on Drug Disposition in Man
NCT00029692
Meditation-Based Treatment for Binge Eating Disorder
NCT00032760
The Use of Reiki for Patients With Advanced AIDS
NCT00032721
Efficacy of Acupuncture With Physical Therapy for Knee Osteo-Arthritis
NCT00035399
Spirituality and Will to Live in Patients With HIV/AIDS
NCT00122902
Immune Restoration by Lipoic Acid in AIDS
NCT00033176
Acupuncture for the Treatment of Chronic Daily Headaches
NCT00086021
Treatment of Multiple Sclerosis Using Over the Counter Inosine
NCT00067327
Developmental Study on Fatigue in Cancer
NCT00034450
Effects of St. John's Wort on the Effectiveness of Oral Contraceptives
NCT00026013
Ginkgo Biloba Extract and the Insulin Resistance Syndrome
NCT00032474
St. John's Wort Versus Placebo in Social Phobia
NCT00035412
Consistency of Traditional Chinese Medicine Diagnoses and Herbal Prescriptions for Rheumatoid Arthritis
NCT00071149
Study of Noni in Cancer Patients
NCT00033878
Acupuncture for Shortness of Breath in Cancer Patients
NCT00067691
Creatine Therapy for Huntington's Disease
NCT00026988
Iscar for Supplemental Care in Stage IV Lung Cancer
NCT00079794
Chiropractic Care, Medication, and Self-Care for Neck Pain
NCT00029770
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
NCT00070967
Herb-Opioid Interactions
NCT00027014
Socioeconomic Influences on Complementary and Alternative Medicine Use in Cancer Treatment
NCT00087932
Evaluation of Echinacea for the Common Cold
NCT00032500
Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
NCT00096798
Effects of Creatine and Resistance Exercise Training in People With HIV Infection
NCT00484627
Screening Herbs for Drug Interactions
NCT00029263
The Effects of Music Therapy-Based Stress Reduction on Bone Marrow Transplant Recipients
NCT00032409
Soy Protein in Early Diabetic Nephropathy
NCT00067678
Acupuncture in Cardiovascular Disease
NCT00032422
Brain Imaging Technology to Examine the Effects of Meditation
NCT00082160
Complementary/Alternative Medicine for Abnormality in the Vestibular (Balance) System
NCT00032383
Yoga as a Treatment for Insomnia
NCT00033865
Effects of Lutein in Retinitis Pigmentosa
NCT00029289
Efficacy of Osteopathic Manipulation in Chronic Obstructive Pulmonary Disease
NCT00034112
Massage Therapy for Cancer-Related Fatigue
NCT00039793
Adolescents' Use of Complementary and Alternative Medicine
NCT00032656
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
NCT00010829
Distant Healing for HIV/AIDS
NCT00079534
Identification of the Cranberry Juice Compounds That Prevent Urinary Tract Infections
NCT00087828
Ginkgo Biloba Prevention Trial in Older Individuals
NCT00010803
Biomarkers of Homeopathy in Fibromyalgia
NCT00065702
Dehydroepiandrosterone Effects on HIV-1 Replication
NCT00065104
Valerian to Improve Sleep in Patients With Parkinson's Disease
NCT00070928
Borage Oil and Ginkgo Biloba (EGb 761) in Asthma
NCT00029679
Efficacy of Hyperbaric Oxygen Therapy in Laryngectomy Patients
NCT00026975
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 50 |
| Phase 2 | 92 |
| Phase 3 | 14 |
| Phase 4 | 1 |
Therapeutic Areas
What is open in the National Center for Complementary and Integrative Health (NCCIH) pipeline
6 recruiting of 203 indexed (3% open); 189 completed (93%).
Phase mix: 15 late (III/IV) vs 142 early (I/II) (early-phase heavy).
Top condition: HIV Infections (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Center for Complementary and Integrative Health (NCCIH): open-pipeline peers nationwide
Peers matched on 203 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
National Center for Complementary and Integrative Health (NCCIH) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 203 trials (± recruiting share)
- The University of Texas Medical Branch, Galveston · 203 trials · 14% recruiting
- MedImmune · 210 trials · 0% recruiting
- Genzyme, a Sanofi Company · 196 trials · 2% recruiting
- OHSU Knight Cancer Institute · 211 trials · 17% recruiting
Sponsors near 3% open enrollment (± trial volume)
- Idorsia Pharmaceuticals · 3% recruiting · 34 trials
- Klein Buendel · 3% recruiting · 34 trials
- Kyowa Kirin · 3% recruiting · 34 trials
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · 3% recruiting · 138 trials
Related
What to do with this National Center for Complementary and Integrative Health (NCCIH) page
203 registered trials is a research-attention snapshot, not an endorsement of National Center for Complementary and Integrative Health (NCCIH) or any single study.
- 6 of National Center for Complementary and Integrative Health (NCCIH)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV Infections is the condition National Center for Complementary and Integrative Health (NCCIH) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Center for Complementary and Integrative Health (NCCIH) pipeline card: 203 registered trials from official public datasets.Report a data error.